ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 092,11
-0,61%
Dow Jones
39 601,74
-0,68%
DAX
18 680,20
-0,25%
Brent Oil
81,515
-1,13%
Bitcoin
69 602,27
-0,75%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ASLAN Pharmaceuticals Ltd (ASLN)

  7. ASLAN Pharmaceuticals Ltd (ASLN) Actualités

ASLN

ASLAN Pharmaceuticals (ASLN)

ASLAN Pharmaceuticals Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ASLN
DateHeureSourceTitreSymboleSociété
09/05/202413h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
14/02/202422h45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
18/08/202313h33Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/07/202314h09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ASLNASLAN Pharmaceuticals Ltd
28/04/202313h29Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/04/202323h27Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/04/202322h28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
24/03/202312h33Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
20/03/202322h21Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/03/202314h31Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
14/02/202322h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/11/202221h08Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
31/10/202211h15TipRanksH.C. Wainwright Sticks to Their Buy Rating for Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
15/09/202212h15TipRanksH.C. Wainwright Remains a Buy on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
13/09/202222h06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
15/08/202212h25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
23/05/202212h26TipRanksAslan Pharmaceuticals (ASLN) Receives a Buy from H.C. WainwrightNASDAQ:ASLNASLAN Pharmaceuticals Ltd
28/03/202212h26TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Aslan Pharmaceuticals (ASLN)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
25/03/202212h54Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
06/08/202113h46Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
25/05/202113h30GlobeNewswire Inc.ASLAN Pharmaceuticals to Participate In Fireside Chat at Jefferies Virtual Healthcare ConferenceNASDAQ:ASLNASLAN Pharmaceuticals Ltd
11/05/202113h30GlobeNewswire Inc.ASLAN Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:ASLNASLAN Pharmaceuticals Ltd
05/05/202111h22GlobeNewswire Inc.ASLAN Pharmaceuticals to Present Data on ASLAN004 at Society for Investigative DermatologyNASDAQ:ASLNASLAN Pharmaceuticals Ltd
22/04/202113h51GlobeNewswire Inc.ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateNASDAQ:ASLNASLAN Pharmaceuticals Ltd
01/04/202112h13Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
26/03/202121h19Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:ASLNASLAN Pharmaceuticals Ltd
18/03/202112h27GlobeNewswire Inc.ASLAN Pharmaceuticals Appoints Dr Kathleen Metters as Independent DirectorNASDAQ:ASLNASLAN Pharmaceuticals Ltd
03/03/202106h42GlobeNewswire Inc.ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary SharesNASDAQ:ASLNASLAN Pharmaceuticals Ltd
01/03/202122h01GlobeNewswire Inc.ASLAN Pharmaceuticals Announces Proposed Public Offering of American Depositary SharesNASDAQ:ASLNASLAN Pharmaceuticals Ltd
01/03/202112h00GlobeNewswire Inc.ASLAN Pharmaceuticals Announces Positive Interim Data From the Multiple Ascending Dose Study of ASLAN004 in Atopic Dermatitis...NASDAQ:ASLNASLAN Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:ASLN

Dernières Valeurs Consultées

BITMOT
916560
Gs Group Mc Fb27 Eur
ASX
MI6
Minerals 260
NASDAQ
PCJZX
Putnam Retirement Advant...
LSE
RARE
Wt Etmtl & Rare
BIT
F05703
Vontobel Financial Produ...
COIN
CZEBTC
KOSPI
018250
Aekyung Industrial
BINA
XVGETH
Verge
NYSE
TV
Grupo Televisa
USOTC
SXGDF
Southern Cross Gold (PK)
USOTC
MNDJF
Mandalay Resources (QB)
LSE
AFHD
COIN
INTERGBP
Inter Milan
NASDAQ
PBSK
LSE
SKC
LSE
GMAA
Gama Aviation
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés